LOMUSTINE for Neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 19 adverse event reports in the FDA FAERS database where LOMUSTINE was used for Neoplasm malignant.
Most Reported Side Effects for LOMUSTINE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 169 | 10.5% | 165 | 1 |
| Off label use | 135 | 8.4% | 38 | 33 |
| Thrombocytopenia | 127 | 7.9% | 41 | 54 |
| Disease progression | 106 | 6.6% | 28 | 20 |
| Neutropenia | 92 | 5.7% | 40 | 48 |
| Drug ineffective | 88 | 5.5% | 54 | 26 |
| Fatigue | 71 | 4.4% | 10 | 21 |
| Nausea | 68 | 4.2% | 2 | 20 |
| Platelet count decreased | 63 | 3.9% | 2 | 19 |
| Malignant neoplasm progression | 62 | 3.8% | 16 | 12 |
| Product use in unapproved indication | 58 | 3.6% | 11 | 13 |
| Vomiting | 58 | 3.6% | 16 | 12 |
| Seizure | 57 | 3.5% | 11 | 34 |
| Febrile neutropenia | 47 | 2.9% | 9 | 19 |
| Headache | 44 | 2.7% | 17 | 12 |
Other Indications for LOMUSTINE
Brain neoplasm malignant (291)
Glioblastoma (163)
Medulloblastoma (123)
Product used for unknown indication (106)
Acute myeloid leukaemia (70)
Glioma (58)
Hodgkin's disease (53)
Brain neoplasm (48)
Astrocytoma (32)
Oligodendroglioma (31)
Other Drugs Used for Neoplasm malignant
PALBOCICLIB (1,996)
CAPECITABINE (1,493)
PEMBROLIZUMAB (1,135)
PACLITAXEL (984)
CARBOPLATIN (977)
NIVOLUMAB (947)
OXALIPLATIN (823)
PAZOPANIB (716)
CYCLOPHOSPHAMIDE (685)
FLUOROURACIL (676)